Factors such as genetic mutations (e.g., p53 mutations), hypoxia, nutritional status, inflammatory response, and therapeutic interventions influence the composition of the tumor secretome, thereby altering overall tumor progression. This evidence concerns the gene TP53 and neoplasm.